Understanding patient experiences with lung cancer screening
Official title: CPRIT: Patient Adherence to Lung Cancer Screening
Run by M.D. Anderson Cancer Center · NCT06872723 · Data updated 2026-11-12
This study is trying to understand what makes it hard for people to get lung cancer screenings and how their experiences with scheduling these screenings can be improved.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 340 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | March 21, 2025 |
| Main results expected | February 28, 2029 |
| Study ends | February 28, 2031 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT06872723 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include current smokers or individuals who have quit within the past 15 years with a significant smoking history.
✕Probably not a fit
Patients who do not have an order for lung cancer screening or those without a relevant smoking history may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify barriers to lung cancer screening and assess patient experiences with scheduling these screenings. It will analyze rates of lung cancer screening at the UTMB and UT Tyler programs and utilize advanced machine learning techniques to create predictive models for adherence to screening guidelines. Participants will be surveyed about their experiences, and interviews will be conducted with those who do not complete their screenings as well as with program directors to identify factors influencing screening rates.
Why it matters
Potential benefit: If successful, this study could enhance lung cancer screening rates and improve early detection among at-risk populations.
How similar studies have gone: Other studies have shown success in using predictive modeling and patient feedback to improve screening adherence, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current smoker or quit within the past 15 years * A 20+ pack-year smoking history * Healthy enough for treatment Exclusion Criteria: * Not applicable as our focus is on patients with an order for screening at the UTMB or UT Tyler
Where it's running
-
MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Robert Volk, PHD — M.D. Anderson Cancer Center
- Study coordinator: Robert Volk, PHD
- Email: bvolk@mdanderson.org
- Phone: 713-563-2509
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Empowering patients to get lung cancer screening with support and navigation
This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.
-
Quality Implementation of Lung Cancer Screening in Kentucky
This project tests how well the QUILS system helps Kentucky lung cancer screening programs work together to screen at-risk residents more effectively.
-
Statewide Lung Cancer Screening Improvement in Nevada and Mississippi using the QUILS System
This project tests whether a QUILS-based statewide initiative can expand and sustain high-quality lung cancer screening for people in Mississippi and Nevada.
-
Quality Improvement Implementation for Lung Cancer Screening (QUILS) Program Enhancement
This project tests a quality improvement pathway in existing lung cancer screening programs to help identify and prioritize process changes that improve quality and patient retention.
-
Methylation markers from saliva to guide lung cancer screening
This study tests whether DNA methylation patterns in saliva can more accurately identify people who should get a low-dose CT scan for lung cancer screening.
-
Multilevel program to increase LDCT lung cancer screening and help African American smokers quit
This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.